Patents by Inventor Paul Deutsch

Paul Deutsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of nitrogen substituted aminotetralins derivatives
    Patent number: 8981121
    Abstract: The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: March 17, 2015
    Assignee: UCB Pharma GmbH
    Inventors: Celal Ates, Arnaud Schule, Magali Palacio, Paul Deutsch, David Vasselin, Nicolas Carly, Ganesh Phadtare, Swapnil Yerande, Jean-Pierre Delatinne, Maria Luisa Escudero Hernandez, Veronique Pinilla
  • Novel Process for the Preparation of Nitrogen Substituted Aminotetralins Derivatives
    Publication number: 20130102794
    Abstract: The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    Type: Application
    Filed: June 24, 2011
    Publication date: April 25, 2013
    Applicant: UCB PHARMA GMBH
    Inventors: Celal Ates, Arnaud Schule, Magali Palacio, Paul Deutsch, David Vasselin, Nicolas Carly, Ganesh Phadtare, Swapnil Yerande, Jean-Pierre Delatinne, Maria Luisa Escudero Hernandez, Veronique Pinilla
  • Methods of using SAHA and Erlotinib for treating cancer
    Publication number: 20070197568
    Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor such as suberoylanilide hydroxamic acid (SAHA), or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of one or more anti-cancer agents, including Erlotinib. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.
    Type: Application
    Filed: November 3, 2006
    Publication date: August 23, 2007
    Inventors: Paul Bunn, Samir Witta, Victoria Richon, Stanley Frankel, Paul Deutsch, Sophia Randolph
  • Methods of using SAHA and Bortezomib for treating cancer
    Publication number: 20070197473
    Abstract: The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor such as suberoylanilide hydroxamic acid (SAHA), or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of one or more anti-cancer agents, including Bortezomib. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.
    Type: Application
    Filed: November 3, 2006
    Publication date: August 23, 2007
    Inventors: Stanley Frankel, Paul Deutsch, Sophia Randolph, Bernard Fine
  • Tilt-up panel bracket
    Patent number: 4104356
    Abstract: An improved reusable bracket for securing wood forms for the pouring of concrete tilt-up panels has a base which is fastened to the concrete deck with a powder-driven fastener and an upstanding portion. The opposite side edges of the bracket abut the forms for two adjacent panels. Tabs on the bracket have oblique holes for nailing the bracket to the form. The bracket can be removed by a single blow on the upstanding member.
    Type: Grant
    Filed: January 26, 1977
    Date of Patent: August 1, 1978
    Inventors: Joseph Paul Deutsch, Ray A. Jones